Compile Data Set for Download or QSAR
Report error Found 28 Enz. Inhib. hit(s) with all data for entry = 10062
TargetNitric oxide synthase, inducible(Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511498(US11059792, Compound T12)
Affinity DataIC50: 11.3nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND 96 well plates (Corning, N.Y.) in a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNitric oxide synthase, inducible(Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511511(US11059792, Compound T25)
Affinity DataIC50: 15.4nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND 96 well plates (Corning, N.Y.) in a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNitric oxide synthase, inducible(Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511492(US11059792, Compound T6)
Affinity DataIC50: 19.4nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND 96 well plates (Corning, N.Y.) in a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNitric oxide synthase, inducible(Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511495(US11059792, Compound T9)
Affinity DataIC50: 22.7nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND 96 well plates (Corning, N.Y.) in a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNitric oxide synthase, inducible(Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511512(US11059792, Compound T26)
Affinity DataIC50: 27.7nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND 96 well plates (Corning, N.Y.) in a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNitric oxide synthase, inducible(Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511494(US11059792, Compound T8)
Affinity DataIC50: 28.8nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND 96 well plates (Corning, N.Y.) in a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNitric oxide synthase, inducible(Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511509(US11059792, Compound T23)
Affinity DataIC50: 31.1nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND 96 well plates (Corning, N.Y.) in a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNitric oxide synthase, inducible(Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511489(US11059792, Compound T3)
Affinity DataIC50: 40.8nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND 96 well plates (Corning, N.Y.) in a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNitric oxide synthase, inducible(Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511508(US11059792, Compound T22)
Affinity DataIC50: 47.8nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND 96 well plates (Corning, N.Y.) in a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNitric oxide synthase, inducible(Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511510(US11059792, Compound T24)
Affinity DataIC50: 48.8nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND 96 well plates (Corning, N.Y.) in a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNitric oxide synthase, inducible(Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511513(US11059792, Compound T27)
Affinity DataIC50: 53.1nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND 96 well plates (Corning, N.Y.) in a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNitric oxide synthase, inducible(Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511496(US11059792, Compound T10)
Affinity DataIC50: 62.8nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND 96 well plates (Corning, N.Y.) in a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNitric oxide synthase, inducible(Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511505(US11059792, Compound T19)
Affinity DataIC50: 82.7nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND 96 well plates (Corning, N.Y.) in a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNitric oxide synthase, inducible(Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511493(US11059792, Compound T7)
Affinity DataIC50: 91.8nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND 96 well plates (Corning, N.Y.) in a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNitric oxide synthase, inducible(Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511497(US11059792, Compound T11)
Affinity DataIC50: 93.2nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND 96 well plates (Corning, N.Y.) in a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNitric oxide synthase, inducible(Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511503(US11059792, Compound T17)
Affinity DataIC50: 120nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND 96 well plates (Corning, N.Y.) in a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNitric oxide synthase, inducible(Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511502(US11059792, Compound T16)
Affinity DataIC50: 132nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND 96 well plates (Corning, N.Y.) in a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNitric oxide synthase, inducible(Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511491(US11059792, Compound TS)
Affinity DataIC50: 136nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND 96 well plates (Corning, N.Y.) in a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNitric oxide synthase, inducible(Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511514(US11059792, Compound T28)
Affinity DataIC50: 138nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND 96 well plates (Corning, N.Y.) in a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNitric oxide synthase, inducible(Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511487(US11059792, Compound T1)
Affinity DataIC50: 151nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND 96 well plates (Corning, N.Y.) in a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNitric oxide synthase, inducible(Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511500(US11059792, Compound T14)
Affinity DataIC50: 222nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND 96 well plates (Corning, N.Y.) in a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNitric oxide synthase, inducible(Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511499(US11059792, Compound T13)
Affinity DataIC50: 233nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND 96 well plates (Corning, N.Y.) in a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNitric oxide synthase, inducible(Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511507(US11059792, Compound T21)
Affinity DataIC50: 407nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND 96 well plates (Corning, N.Y.) in a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNitric oxide synthase, inducible(Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511488(US11059792, Compound T2)
Affinity DataIC50: 471nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND 96 well plates (Corning, N.Y.) in a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNitric oxide synthase, inducible(Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511490(US11059792, Compound T4)
Affinity DataIC50: 662nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND 96 well plates (Corning, N.Y.) in a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNitric oxide synthase, inducible(Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511504(US11059792, Compound T18)
Affinity DataIC50: 693nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND 96 well plates (Corning, N.Y.) in a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNitric oxide synthase, inducible(Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511506(US11059792, Compound T20)
Affinity DataIC50: 1.00E+3nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND 96 well plates (Corning, N.Y.) in a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent

TargetNitric oxide synthase, inducible(Human)
Reata Pharmaceuticals

US Patent
LigandPNGBDBM511501(US11059792, Compound T15)
Affinity DataIC50: 3.00E+3nMAssay Description:RAW 264.7 cells were plated 1 day in advance of experiment at a concentration of 80,000 cells/well onto CellBIND 96 well plates (Corning, N.Y.) in a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2022
Entry Details
Go to US Patent